Éva Ágai-Csongor

Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist–Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile

Béla Kiss, Attila Horváth, Zsolt Némethy et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 358 citations

Discovery of cariprazine (RGH-188): A novel antipsychotic acting on dopamine D3/D2 receptors

Éva Ágai-Csongor, György Domány, Katalin Nógrádi et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 89 citations · Full text

Medicinal Chemistry, Dopamine D3/d2 Receptors, Psychoactive Drug +8

Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: I. neurochemical characterisation of RG-15

Béla Kiss, I. Laszlovszky, Attila Horváth et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2008 · 60 citations

Psychiatry, I. Neurochemical Characterisation, Medicine +10

Indole-2-carboxamides as novel NR2B selective NMDA receptor antagonists

István Borza, Sándor Kolok, Anikó Gere et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 36 citations · Full text

Functional Selectivity, Medicine, Mechanism Of Action +5

Multiple Fragment Docking and Linking in Primary and Secondary Pockets of Dopamine Receptors

Márton Vass, Éva Ágai-Csongor, Ferenc Horti et al. · ACS Medicinal Chemistry Letters · 2014 · 34 citations · Full text

Drug Target, Molecular Biology, Dopamine Receptors +20